(Q70904702)
Statements
Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor (English)
H Renz
K Bradley
K Enssle
J E Loader
G L Larsen
1 February 1996